Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease

Journal of Molecular Neuroscience

Volumn 47, Issue 1, 2012, Pages 113-119

  Wang, Jieyu ^b   Xu, Huamin ^a   Jiang, Hong ^a   Du, Xixun ^a   Sun, Peng ^b   Xie, Junxia ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

6 Hydroxydopamine; Iron; Neurorescue; Parkinson's disease; Rosmarinic acid

Indexed keywords

DOPAMINE; IRON; OXIDOPAMINE; PROTEIN BAX; PROTEIN BCL 2; ROSMARINIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; FEMALE; GENE EXPRESSION; IMMUNOREACTIVITY; NONHUMAN; PARKINSON DISEASE; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CINNAMATES; DEPSIDES; DISEASE MODELS, ANIMAL; FEMALE; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SYMPATHOLYTICS;

RATTUS;

EID: 84859753314     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9693-1     Document Type: Article

References (32)

1. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65:135-172 (Pubitemid 32524182)
2. Du T, Li L, Song N, Xie J, Jiang H (2010a) Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23.5 dopaminergic cells. Int J Toxicol 29:625-633
3. Du T, Song N, Xie J, Jiang H (2010b) Iron chelation of rosmarinic acid. Med J Qilu 25:399-401
4. Earl CD, Reum T, Xie JX, Sautter J, Kupsch A, OertelWH,Morgenstern R (1996) Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson's disease: in vivo voltammetric data. Exp Brain Res 109:179-184
5. Emdadul Haque M, Asanuma M, Higashi Y, Miyazaki I, Tanaka K, Ogawa N (2003) Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim Biophys Acta 1619:39-52 (Pubitemid 35462118)
6. Gal S, Zheng H, Fridkin M, Youdim MB (2010) Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30. Neurotox Res 17:15-27
7. Gao LP, Wei HL, Zhao HS, Xiao SY, Zheng RL (2005) Antiapoptotic and antioxidant effects of rosmarinic acid in astrocytes. Pharmazie 60:62-65
8. Gao QG, Chen WF, Xie JX, Wong MS (2009) Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways. J Neurochem 109:1338-1347
9. Iuvone T, De Filippis D, Esposito G, D'Amico A, Izzo AA (2006) The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther 317:1143-1149 (Pubitemid 43764118)
10. Jiang H, Luan Z, Wang J, Xie J (2006) Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 49:605-609 (Pubitemid 44528090)
11. Jiang H, Song N, Wang J, Ren LY, Xie JX (2007) Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem Int 51:32-36 (Pubitemid 47002045)
12. Jiang H, Song N, Xu H, Zhang S, Wang J, Xie J (2010) Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent. Cell Res 20:345-356
13. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274-1277 (Pubitemid 24036095)
14. Ke Y, Qian ZM (2003) Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2:246-253 (Pubitemid 37443312)
15. Korsmeyer SJ (1995) Regulators of cell death. Trends Genet 11:101-105
16. Lee HJ, Cho HS, Park E, Kim S, Lee SY, Kim CS, Kim do K, Kim SJ, Chun HS (2008) Rosmarinic acid protects human dopaminergic neuronal cells against hydrogen peroxide-induced apoptosis. Toxicology 250:109-115
17. Ma ZG, Wang J, Jiang H, Liu TW, Xie JX (2007) Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats. Neuroreport 18:1181-1185 (Pubitemid 46988076)
18. Mandel S, Grunblatt E, Riederer P, Gerlach M, Levites Y, Youdim MB (2003) Neuroprotective strategies in Parkinson's disease: an update on progress. CNS Drugs 17:729-762 (Pubitemid 37000010)
19. Offen D, Beart PM, Cheung NS, Pascoe CJ, Hochman A, Gorodin S, Melamed E, Bernard R, Bernard O (1998) Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc Natl Acad Sci U S A 95:5789-5794 (Pubitemid 28224175)
20. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619 (Pubitemid 23259742)
21. Onyango IG (2008) Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Neurochem Res 33:589-597
22. Petersen M, Simmonds MS (2003) Rosmarinic acid. Phytochemistry 62:121-125 (Pubitemid 36857578)
23. Ren P, Jiang H, Li R, Wang J, Song N, Xu HM, Xie JX (2009) Rosmarinic acid inhibits 6-OHDA-induced neurotoxicity by anti-oxidation in MES23.5 cells. J Mol Neurosci 39:220-225
24. Rouault TA (2001) Iron on the brain. Nat Genet 28:299-300
25. Sayre LM, Perry G, SmithMA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21:172-188 (Pubitemid 351219718)
26. Swarup V, Ghosh J, Ghosh S, Saxena A, Basu A (2007) Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother 51:3367-3370 (Pubitemid 350067554)
27. Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S (2001) Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 98:2837-2842 (Pubitemid 32209570)
28. Wang J, Jiang H, Xie JX (2004) Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system. Neurochem Res 29:2239-2243 (Pubitemid 40036895)
29. Wang J, Xu HM, Yang HD, Du XX, Jiang H, Xie JX (2009) Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochem Int 54:43-48
30. Youdim MB, Stephenson G, Ben Shachar D (2004) Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann N YAcad Sci 1012:306-325 (Pubitemid 38453534)
31. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863-873 (Pubitemid 39482155)
32. Zhao J, Huang X, Tang W, Ren P, Xing Z, Tian X, Zhu Z, Wang Y (2007) Effect of oriental herbal prescription Guan-Xin-Er-Hao on coronary flow in healthy volunteers and antiapoptosis on myocardial ischemia-reperfusion in rat models. Phytother Res 21:926-931 (Pubitemid 47582765)